Company Description
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States.
The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.
It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars.
In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services.
It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process.
The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025.
Claritev Corporation was founded in 1980 and is headquartered in New York, New York.
| Country | United States |
| Founded | 1980 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 2,700 |
| CEO | Travis Dalton |
Contact Details
Address: 115 Fifth Avenue New York, New York 10003 United States | |
| Phone | 212 780 2000 |
| Website | claritev.com |
Stock Details
| Ticker Symbol | CTEV |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001793229 |
| CUSIP Number | 62548M209 |
| ISIN Number | US62548M2098 |
| Employer ID | 84-3536151 |
| SIC Code | 7389 |
Key Executives
| Name | Position |
|---|---|
| Travis S. Dalton | Chief Executive Officer, President and Chairman |
| Douglas M. Garis | Executive Vice President and Chief Financial Officer |
| Jerome W. Hogge III | Executive Vice President and Chief Operating Officer |
| Michael C. Kim | Executive Vice President and Chief Digital Officer |
| Tiffani D. Misencik | Senior Vice President and Chief Growth Officer |
| Jason Wong | Senior Vice President of Treasury and Investor Relations |
| Tara A. O'Neil | Senior Vice President and General Counsel |
| Melissa Humphrey | Senior Vice President of Marketing and Communications |
| Alwyn Van Heerdan | Vice President of Strategy and Corporate Development |
| Carol H. Nutter | Senior Vice President and Chief People Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 7, 2025 | S-3 | Registration statement under Securities Act of 1933 |
| Aug 7, 2025 | 10-Q | Quarterly Report |
| Aug 6, 2025 | 8-K | Current Report |
| May 9, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| May 9, 2025 | 10-Q | Quarterly Report |
| May 8, 2025 | 8-K | Current Report |
| May 1, 2025 | 8-K | Current Report |
| Mar 19, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 19, 2025 | DEF 14A | Other definitive proxy statements |
| Mar 5, 2025 | 8-K | Current Report |